Organisation: Novartis AG

New report reveals that trademark filing activity has resumed growth in Australia after a significant decline in 2022, with foreign applications rising.

23 May 2024

USPTO Trademark Commissioner David Gooder sits down with WTR to outline key developments and challenges at the agency over the past 12 months. 

21 December 2023

WTR data analysis uncovers the companies filing the highest number of trademarks in-house – and those filing the highest number across the globe.

20 December 2023

Data analysis reveals the companies with the largest trademark portfolios in the Association of Southeast Asian Nations – and evolving trends among the most active filers.

16 October 2023

We scrutinise the data to reveal the 50 companies with the largest portfolios in five major jurisdictions.

13 July 2023

The General Court underlined the particularly high level of attention of the relevant public when it comes to medicines that have a direct impact on their health.

03 April 2023

New data from WIPO reveals a significant drop in international trademark applications last year, but closer analysis offers optimism for the long-term outlook.

28 February 2023

The CJEU’s decision in this case - together with the other decisions issued on 17 November 2022 - provides important guidance for trademark owners and parallel importers in the pharmaceutical industry.

10 January 2023

This case shows that it is reasonable for a party to doubt the merits of a preliminary indication issued by the UKIPO when it is not in its favour.

04 January 2023

In an exclusive feature-length article, WIPO’s Denis Croze, Director, Madrid Information and Promotion Division, Madrid Registry, examines how the Madrid System continues to grow in terms of membership and use, and reveals some of the changes and improvements planned for the years ahead.

01 September 2022